BioSpace News Archive

BioCapital

MicroPort Orthopedics Announces Second Annual Global Medial-Pivot Symposium in Phoenix, Arizona from October 13-14

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, announces that registration is open for its second annual Global Medial-Pivot Symposium in Phoenix, Arizona from October 13-14, 2023.

May 1, 2023
·
3 min read
Business

Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care

Flatiron Health announced a new collaboration today with Sanofi in their pursuit to redesign the clinical trial experience for sponsors, sites, and patients in the therapeutic area of oncology.

May 1, 2023
·
3 min read
FDA

Medtronic receives FDA approval for its next generation Micra leadless pacing systems

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra™ AV2 and Micra™ VR2, the next generation of its industry-leading miniaturized, leadless pacemakers.

May 1, 2023
·
4 min read
Genetown

Ardelyx Announces Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with IBS-C, to be Presented at the 2023 Digestive Disease Week Conference

Ardelyx, Inc. announced that additional data supporting the efficacy and safety of IBSRELA will be presented in a poster at the 2023 Digestive Disease Week Conference to be held May 6-9, 2023, in Chicago, Illinois.

May 1, 2023
·
5 min read
InspireMD Announces Successful First-in-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent (CAS) Platform

InspireMD, Inc., developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, announced that the first carotid artery disease patient has been treated utilizing CGuard Prime, the company’s next generation CAS stent platform.

May 1, 2023
·
6 min read
BioCapital

I-MAB Filed 2022 Annual Report on Form 20-F

I-Mab announced that it has filed its annual report on Form 20-F for the year ended December 31, 2022 with the U.S. Securities and Exchange Commission on May 1, 2023.

May 1, 2023
·
1 min read
Biotech Beach

Poseida Therapeutics to Present at BofA Securities 2023 Health Care Conference

Poseida Therapeutics, Inc. today announced that it will participate in the BofA Securities 2023 Health Care Conference on Wednesday, May 10, 2023 at 3:15pm PT | 6:15pm ET in Las Vegas.

May 1, 2023
·
1 min read
Genetown

TransMedics Releases Inaugural Environmental, Social & Governance (ESG) Report

TransMedics Group, Inc., a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced that it has published its inaugural Environmental, Social & Governance report.

May 1, 2023
·
2 min read
With $75 Million from Apple Tree Partners, Initial Therapeutics Launches to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets

Initial was created to take on undruggable disease-causing proteins by discriminately intercepting their translation in the exit tunnel of the ribosome

May 1, 2023
·
4 min read
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for investigational IDP-126 (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%) Gel with a Prescription Drug User Fee Act (PDUFA) action date of October 20, 2023.

May 1, 2023
·
4 min read